News search

The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease

The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.

A new policy paper highlights key areas for advancing data-driven policymaking to curb the rising burden of non-communicable diseases (NCDs), setting the stage for a more effective and equitable healthcare in Europe 

Dr. Alegre-Cebollada will be recognized for the pioneering the study of protein mechanics in living systems, revealing how mechanical forces govern protein function and contribute to human disease.

The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases

ESC calls for a cultural shift to deal with the adverse combination of mental health conditions and cardiovascular disease

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), together with cardiologists from Hospital Universitario Puerta de Hierro and the Spanish cardiovascular disease research network (CIBERCV), report that the new discovery makes it possible to identify high-risk patients early and refer them sooner to specialized heart failure units

Dr. Claudia Monaco, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK